Patent ID: 7404965

Claim:
A pharmaceutical composition in the form of a solution, cream, lotion, spray, ointment, gel, aerosol, tablet, suppository or patch device for transdermal or transmucosal administration of alprazolam to a subject, comprising as a permeation enhancing mixture: a fatty component in an amount of 0.1% to 20% by weight and comprising a saturated fatty alcohol of formula CH 3 —(CH 2 ) n —CH 2 OH, or an unsaturated fatty alcohol of formula CH 3 (C n H 2(n−1) )—OH, wherein n is an integer of between 8 and 22; and a vehicle comprising a monoalkylether of diethyleneglycol, a C 1 -C 4 alkanol, a polyalcohol, and water.